AzTrials
AzTrials

Internet AddictionNCT05897359

The Use of Nursing-students-led bCBTMI

A study testing bCBTMI in people with Internet Addiction, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The use of the internet is very popular in adolescence. Notwithstanding the benefits from the internet, many users are addicted to the internet and develop problematic behaviours which are regarded as "Internet addiction" (IA). Read more about this study

Who is it for?
Ages 13 to 17 years
Conditions the study is for
Internet Addiction
What is being tested?
bCBTMI
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteHong Kong
Study dates
1 Sep 2022to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Aged 13 to 17
  • Studying Forms 2 to 4
  • Classified as IA by the Chinese version of Young's 10-item Internet Addiction Test (IAT)
  • Can communicate in Cantonese and read Chinese.

Who cannot join

  • With physical or cognitive impairment and learning problems as identified from the medical records

Trial locations and contacts

1 site in 1 country.

Ka Wai Katherine Lam contact

27666420

kw-katherine.lam@polyu.edu.hk

Hong Kong1 site, 1 recruiting
  • Katherine Lam

    Hong Kong, Hong Kong,China, 0000

    Katherine Lam, Phd

    Recruiting

Other trials in Hong Kong

About this study

Official title: The Use of Nursing-students-led bCBTMI for Internet Addiction Among Adolescents: a Feasibility Cluster Randomised Controlled Trial

The use of the internet is very popular in adolescence. Notwithstanding the benefits from the internet, many users are addicted to the internet and develop problematic behaviours which are regarded as "Internet addiction" (IA). Trained nursing students, who are the future nurses and well-equipped with basic health knowledge, as the interventionists to deliver a bCBTMI intervention to the eligible subjects. The result of this study is expected to provide evidence of the feasibility and effectiveness of training nursing students to conduct bCBTMI in Hong Kong Chinese adolescents with IA for a definitive RCT.

Read the detailed description

A two-arm, parallel-group, feasibility cluster randomized controlled trial will be conducted. 60 adolescents with IA will be recruited from secondary schools in Hong Kong. Participants in the intervention group will receive 4 weekly 30-45 minute sessions using the brief CBT and the brief MI models by nursing students. Control group participants will receive routine care for IA.

Being tested
bCBTMI, Control
Keywords
Adolescents, Nursing-students-led, Cognitive Behavioural therapy, Motivational Interviewing
Medical subject headings
Internet Addiction Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bCBTMIBehavioural

    This experimental group involves 4 weekly 30-45 minute sessions using the brief CBT and the brief MI models by trained nursing students.

  • ControlBehavioural

    The control group will receive health talks about internet addiction consequences and impacts on young people by nursing students who are not involved in the intervention group to mimic the time and attention spent on the intervention group. These health talks are considered routine care for IA health promotion.

Study groups in NCT05897359
Study groupRoleWhat they receive
bCBTMIExperimentalbCBTMI care for IA.
Receives: Behavioral: bCBTMI
ControlPlacebo comparatorRoutine care for IA.
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Screening rate

    Calculated as the number of students screened at participated secondary schools divided by number of students at participated schools during the recruitment period.

    Measured: at day 1

  2. Eligibility rate

    Calculated by dividing the number of secondary school students who are eligible by the number who are screened.

    Measured: at day 1

  3. Consent rate

    Calculated by dividing the number of secondary school students who consent to join the study by the number who are eligible.

    Measured: at the 6-month follow-up

  4. Randomization rate

    Calculated by dividing the number of secondary school students who are randomized into intervention and control groups by those who provide consent.

    Measured: at day 1

  5. Attendance rate

    Calculated by dividing the number of secondary school students who complete the intervention by those who are randomized.

    Measured: Immediately after the bCBTMI intervention

  6. Retention rate

    Calculated by dividing the number of secondary school students who remain in the study by those who are randomized. Retention rates for the intervention and control groups will be calculated at each follow-up.

    Measured: at the 6-month follow-up

  7. Adherence to intervention protocol

    Calculated by dividing the number of secondary school students who follow the intervention protocol by those who are randomized.

    Measured: at the 1-month follow-up

  8. Complete rate

    Calculated by dividing the number of secondary school students who returned questionnaires by the number of questionnaires distributed. This will be calculated by groups at baseline and each follow-up.

    Measured: at the 6-month follow-up

  9. Missing data

    Calculated as the percentage of missing values in the dataset. Unknown or blank values will be considered missing values.

    Measured: at the 6-month follow-up

  10. Adverse events

    Are defined as unfavorable and unintended events that are not present at baseline, or appear to have worsened during the study. The relation to the intervention will be assessed in accordance with the protocol for adverse events management (It can be provided upon request). The number and event severity will be recorded. Numbers and reasons for exclusions will be noted.

    Measured: at the 6-month follow-up

Secondary outcomes (16)
  1. Self-reported abstinence at the 1-week follow-up

    Measured by the number of IA symptoms via a self-reported questionnaire.

    Measured: at the 1-week follow-up

  2. Self-reported abstinence at the 1-month follow-up

    Measured by the number of IA symptoms via a self-reported questionnaire.

    Measured: at the 1-month follow-up

  3. Self-reported abstinence at the 3-month follow-up

    Measured by the number of IA symptoms via a self-reported questionnaire.

    Measured: at the 3-month follow-up

  4. Self-reported abstinence at the 6-month follow-up

    Measured by the number of IA symptoms via a self-reported questionnaire.

    Measured: at the 6-month follow-up

  5. The Chinese version of Center for Epidemiologic Studies Depression Scale for Children (CES-DC)

    CES-DC will be used to record the number of depression symptoms in secondary schools students with IA at each follow-up. It includes 20 items asking on a 4-point Likert scale in relation to the incidence of the stated symptoms during the previous week, and are scored from 0 to 3 (0 = not at all, 3 = a lot). Total scores range from 0 to 60, with higher scores indicating greater number of depressive symptoms. This questionnaire has been empirically tested and validated in Hong Kong children and are currently using in Youth Quitline.

    Measured: at the 1-week follow-up

  6. The Chinese version of Center for Epidemiologic Studies Depression Scale for Children (CES-DC)

    CES-DC will be used to record the number of depression symptoms in secondary schools students with IA at each follow-up. It includes 20 items asking on a 4-point Likert scale in relation to the incidence of the stated symptoms during the previous week, and are scored from 0 to 3 (0 = not at all, 3 = a lot). Total scores range from 0 to 60, with higher scores indicating greater number of depressive symptoms. This questionnaire has been empirically tested and validated in Hong Kong children and are currently using in Youth Quitline.

    Measured: at the 1-month follow-up

  7. The Chinese version of Center for Epidemiologic Studies Depression Scale for Children (CES-DC)

    CES-DC will be used to record the number of depression symptoms in secondary schools students with IA at each follow-up. It includes 20 items asking on a 4-point Likert scale in relation to the incidence of the stated symptoms during the previous week, and are scored from 0 to 3 (0 = not at all, 3 = a lot). Total scores range from 0 to 60, with higher scores indicating greater number of depressive symptoms. This questionnaire has been empirically tested and validated in Hong Kong children and are currently using in Youth Quitline.

    Measured: at the 3-month follow-up

  8. The Chinese version of Center for Epidemiologic Studies Depression Scale for Children (CES-DC)

    CES-DC will be used to record the number of depression symptoms in secondary schools students with IA at each follow-up. It includes 20 items asking on a 4-point Likert scale in relation to the incidence of the stated symptoms during the previous week, and are scored from 0 to 3 (0 = not at all, 3 = a lot). Total scores range from 0 to 60, with higher scores indicating greater number of depressive symptoms. This questionnaire has been empirically tested and validated in Hong Kong children and are currently using in Youth Quitline.

    Measured: at the 6-month follow-up

  9. Anxiety level

    The anxiety level of secondary school students with IA will be measured by the short form of the Chinese Version of the State Anxiety Scale for Children (CSAS-C) at each follow-up. It has 10 itmes with scores from 1 to 3. Total scores range from 10 to 30, with higher scores indicating a higher level of anxiety. This questionnaire has been empirically tested and validated in Hong Kong children.

    Measured: at the 1-week follow-up

  10. Anxiety level

    The anxiety level of secondary school students with IA will be measured by the short form of the Chinese Version of the State Anxiety Scale for Children (CSAS-C) at each follow-up. It has 10 itmes with scores from 1 to 3. Total scores range from 10 to 30, with higher scores indicating a higher level of anxiety. This questionnaire has been empirically tested and validated in Hong Kong children.

    Measured: at the 1-month follow-up

  11. Anxiety level

    The anxiety level of secondary school students with IA will be measured by the short form of the Chinese Version of the State Anxiety Scale for Children (CSAS-C) at each follow-up. It has 10 itmes with scores from 1 to 3. Total scores range from 10 to 30, with higher scores indicating a higher level of anxiety. This questionnaire has been empirically tested and validated in Hong Kong children.

    Measured: at the 3-month follow-up

  12. Anxiety level

    The anxiety level of secondary school students with IA will be measured by the short form of the Chinese Version of the State Anxiety Scale for Children (CSAS-C) at each follow-up. It has 10 itmes with scores from 1 to 3. Total scores range from 10 to 30, with higher scores indicating a higher level of anxiety. This questionnaire has been empirically tested and validated in Hong Kong children.

    Measured: at the 6-month follow-up

  13. Sleep quality of secondary schools students with IA will be assessed using the Pittsburgh Sleep Quality Index (PSQI)

    It contains 19 items measuring 7 domains: subjective sleep quality, latency, duration, habitual efficiency, disturbances, use of medication, and daytime dysfunction on a 3-point scale (0: no difficulty to 3: severe difficulty) except for the items reporting bedtime and time awake. The sum of the seven component scores produces a global score with higher scores represent poorer subjective sleep quality. It has been validated in Hong Kong children and adolescents previously.

    Measured: at the 1-week follow-up

  14. Sleep quality of secondary schools students with IA will be assessed using the Pittsburgh Sleep Quality Index (PSQI)

    It contains 19 items measuring 7 domains: subjective sleep quality, latency, duration, habitual efficiency, disturbances, use of medication, and daytime dysfunction on a 3-point scale (0: no difficulty to 3: severe difficulty) except for the items reporting bedtime and time awake. The sum of the seven component scores produces a global score with higher scores represent poorer subjective sleep quality. It has been validated in Hong Kong children and adolescents previously.

    Measured: at the 1-month follow-up

  15. Sleep quality of secondary schools students with IA will be assessed using the Pittsburgh Sleep Quality Index (PSQI)

    It contains 19 items measuring 7 domains: subjective sleep quality, latency, duration, habitual efficiency, disturbances, use of medication, and daytime dysfunction on a 3-point scale (0: no difficulty to 3: severe difficulty) except for the items reporting bedtime and time awake. The sum of the seven component scores produces a global score with higher scores represent poorer subjective sleep quality. It has been validated in Hong Kong children and adolescents previously.

    Measured: at the 3-month follow-up

  16. Sleep quality of secondary schools students with IA will be assessed using the Pittsburgh Sleep Quality Index (PSQI)

    It contains 19 items measuring 7 domains: subjective sleep quality, latency, duration, habitual efficiency, disturbances, use of medication, and daytime dysfunction on a 3-point scale (0: no difficulty to 3: severe difficulty) except for the items reporting bedtime and time awake. The sum of the seven component scores produces a global score with higher scores represent poorer subjective sleep quality. It has been validated in Hong Kong children and adolescents previously.

    Measured: at the 6-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2023
  2. Study start1 Sep 2022
  3. Primary completion1 May 2024 (estimated)
  4. Study completion1 May 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05897359
Sponsor's protocol ID
bCBTMI-Adolescents
Status last verified
May 2023
First submitted
11 May 2023
Last updated
9 Jun 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing bCBTMI in people with Internet Addiction, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ka Wai Katherine Lam (27666420, kw-katherine.lam@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Screening rate (time frame: at day 1). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in